Artificial Intelligence Helps Detect Rare Diseases
|
By HospiMedica International staff writers Posted on 18 Jun 2019 |

A child with Kabuki Syndrome (Photo courtesy of Wikimedia).
A new study suggests that an artificial intelligence (AI) neural network can be used to automatically combine portrait photos and genetic data to diagnose rare diseases more efficiently.
The prioritization of exome data by image analysis (PEDIA) project, under development by the University of Bonn (Germany), GeneTalk (Bonn, Germany), Charité University Medicine (Charité; Berlin, Germany), and other institutions, is designed to interpret exome data by analyzing sequence variants in portrait photographs, and integrating the results using the DeepGestalt phenotyping tool, a product of FDNA (Herzliya, Israel), which was trained with around 30,000 portrait pictures of people affected by rare syndromal diseases.
In a proof of concept study, the researchers measured the value added by computer-assisted image analysis to the diagnostic yield on a cohort consisting of 679 individuals with 105 different monogenic disorders. For each separate case, frontal photos, clinical features, and the disease-causing variants were submitted. The results showed that computer-assisted analysis of frontal photos improved the top 1% accuracy rate by more than 20–89%, and the top 10% accuracy rate by more than 5–99% for the disease-causing gene. The study was published on June 5, 2019, in Nature Genetics in Medicine.
“In combination with facial analysis, it is possible to filter out the decisive genetic factors and prioritize genes. Merging data in the neuronal network reduces data analysis time and leads to a higher rate of diagnosis,” said senior author Professor Peter Krawitz, MD, PhD, director of the Institute for Genomic Statistics and Bioinformatics at the University of Bonn. “This is of great scientific interest to us and also enables us to find a cause in some unsolved cases.”
“PEDIA is a unique example of next-generation phenotyping technologies,” said Dekel Gelbman, CEO of FDNA. “Integrating an advanced AI and facial analysis framework such as DeepGestalt into the variant analysis workflow will result in a new paradigm for superior genetic testing.”
Many rare diseases cause characteristic abnormal facial features in those affected, such as Kabuki syndrome, which is reminiscent of the make-up of a traditional Japanese form of theatre. The eyebrows are arched, the eye-distance is wide and the spaces between the eyelids are long. Another example is mucopolysaccharidosis, which leads to bone deformation, stunted growth, and learning difficulties. Such phenotype information has so far only been accessible for bioinformatics workflows after encoding into clinical terms by expert dysmorphologists.
Related Links:
University of Bonn
GeneTalk
Charité University Medicine
FDNA
The prioritization of exome data by image analysis (PEDIA) project, under development by the University of Bonn (Germany), GeneTalk (Bonn, Germany), Charité University Medicine (Charité; Berlin, Germany), and other institutions, is designed to interpret exome data by analyzing sequence variants in portrait photographs, and integrating the results using the DeepGestalt phenotyping tool, a product of FDNA (Herzliya, Israel), which was trained with around 30,000 portrait pictures of people affected by rare syndromal diseases.
In a proof of concept study, the researchers measured the value added by computer-assisted image analysis to the diagnostic yield on a cohort consisting of 679 individuals with 105 different monogenic disorders. For each separate case, frontal photos, clinical features, and the disease-causing variants were submitted. The results showed that computer-assisted analysis of frontal photos improved the top 1% accuracy rate by more than 20–89%, and the top 10% accuracy rate by more than 5–99% for the disease-causing gene. The study was published on June 5, 2019, in Nature Genetics in Medicine.
“In combination with facial analysis, it is possible to filter out the decisive genetic factors and prioritize genes. Merging data in the neuronal network reduces data analysis time and leads to a higher rate of diagnosis,” said senior author Professor Peter Krawitz, MD, PhD, director of the Institute for Genomic Statistics and Bioinformatics at the University of Bonn. “This is of great scientific interest to us and also enables us to find a cause in some unsolved cases.”
“PEDIA is a unique example of next-generation phenotyping technologies,” said Dekel Gelbman, CEO of FDNA. “Integrating an advanced AI and facial analysis framework such as DeepGestalt into the variant analysis workflow will result in a new paradigm for superior genetic testing.”
Many rare diseases cause characteristic abnormal facial features in those affected, such as Kabuki syndrome, which is reminiscent of the make-up of a traditional Japanese form of theatre. The eyebrows are arched, the eye-distance is wide and the spaces between the eyelids are long. Another example is mucopolysaccharidosis, which leads to bone deformation, stunted growth, and learning difficulties. Such phenotype information has so far only been accessible for bioinformatics workflows after encoding into clinical terms by expert dysmorphologists.
Related Links:
University of Bonn
GeneTalk
Charité University Medicine
FDNA
Latest AI News
- AI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
- Machine Learning Approach Enhances Liver Cancer Risk Stratification
- New AI Approach Monitors Brain Health Using Passive Wearable Data
- AI Tool Maps Early Risk Patterns in Bloodstream Infections
- AI Model Identifies Rare Endocrine Disorder from Hand Images
- AI Tool Promises to Reduce Length of Hospital Stays and Free Up Beds
Channels
Critical Care
view channel
Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
Hospitalizations for heart failure with preserved ejection fraction (HFpEF) remain common because lung congestion often worsens before symptoms prompt treatment changes. Missed early decompensation... Read more
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read moreSurgical Techniques
view channel
Ultrasound‑Aided Catheter Treatment Cuts Early Collapse in Pulmonary Embolism
Acute pulmonary embolism can cause rapid hemodynamic deterioration and early death in hospitalized and emergency patients. Systemic thrombolysis can dissolve clots but is limited by a high risk of major... Read more
Ultrasound Technology Aims to Replace Invasive BPH Procedures
Benign prostatic hyperplasia (BPH) is a frequent cause of lower urinary tract symptoms in aging men and often requires invasive procedures or prolonged recovery. With prevalence expected to rise as populations... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
Voice-Driven AI System Enables Structured GI Procedure Documentation
Documentation during gastrointestinal (GI) procedures often competes with real-time clinical decision-making and imposes a significant cognitive burden on physicians. Manual data entry and post-procedure... Read more
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







